Promedior Advances Novel Fibrotic Disease Therapy In Idiopathic Pulmonary Fibrosis
This article was originally published in The Pink Sheet Daily
Executive Summary
The start-up is also testing the ability of its monocyte-modulating approach to prevent scarring in glaucoma surgery.